Disposable Hospital Supplies Market is predicted to reach USD 72.1 Billion at a CAGR of 11.90% during the forecast period 2032

Market Research Future (MRFR) has published on the “Disposable Hospital Supplies Market”

Disposable Hospital Supplies Market Highlights

The global disposable hospital supplies market is accounted to register a CAGR of 11.90% during the forecast period and is estimated to reach USD 72.1 Billion by 2032.

The disposable hospital supplies market is growing as a result of a number of causes, including a rise in surgical procedures, a rise in hospital-acquired infections (HAIs), a rise in the incidence of chronic illnesses that lengthen hospital stays, and the effects of COVID-19 outbreaks over the globe. The COVID-19 outbreak and an increase in hospital admissions around the world have caused a sharp rise in the demand for medical disposables. The WHO has encouraged companies and governments to create 40.00% more personal protective equipment, such as hospital gowns, gloves, surgical masks, face shields, aprons, respirators, and goggles, in order to meet the increased demand globally.

MRFR recognizes the following companies as the key players in the global Disposable Hospital Supplies market—Thermo Fisher Scientific, GENERAL ELECTRIC, BD, Siemens, Boston Scientific Corporation, Stryker, Medtronic, 3M, Zimmer Biomet, Johnson and Johnson Private Limited, Cardinal Health, Koninklijke Philips N.V., Novartis AG, B. Braun Melsungen AG, OSI Systems, Inc., Welch Allyn, Fresenius Medical Care AG and Co. KGaA, Mindray DS USA, MicroPort Scientific Corporation, OandM Halyard, AVITA Medical, Cynosure Inc., and Merz Pharma

Segment Analysis

The global Disposable Hospital Supplies market has been segmented based type, application and end user.

On the basis of type, the market is segmented into diagnostic supplies, dialysis consumables, radiology consumables, infusion products, intubation and ventilation supplies, hypodermic products, sterilization consumables, nonwoven medical supplies, wound care consumables, and others. The sterilization consumables industry led the global market in 2022. Sterilization consumables like cotton swabs, cotton balls, test tubes, and other skin preparation supplies are used to prevent surgical-related infections.

Based on application, the global disposable hospital supplies market has been segmented into cardiovascular, cerebrovascular, ophthalmology, gynecology, urology, orthopedics, and others. The cardiovascular segment will rule the global market for disposable hospital supplies in 2022 due to the increasing prevalence of cardiovascular illnesses worldwide.

Based on end user, the global disposable hospital supplies market has been segmented into hospitals, clinics/physician offices, assisted living centers and nursing homes, ambulatory surgery centers, and research institutes. In 2022, the hospitals segment will rule the world market. A rise in hospital patient admissions for COVID-19 procedures and therapies is the cause of this.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of  Disposable Hospital Supplies Market Research Report

Regional Analysis

The global disposable hospital supplies market, based on region, has been divided into the North America, Europe, Asia-Pacific, and Rest of the World. North America consists of US and Canada. The Europe Disposable Hospital Supplies market comprises of Germany, France, the UK, Italy, Spain, and the rest of Europe. The Disposable Hospital Supplies market in Asia-Pacific has been segmented into China, India, Japan, Australia, South Korea, and the rest of Asia-Pacific. The Rest of the World Disposable Hospital Supplies market comprises of Middle East, Africa, and Latin America.

The largest market share for disposable hospital supplies was maintained by the North American regional sector. The growing number of operations and the presence of significant industry players in North America are driving the regional market's expansion. The market for medical disposables has also grown as a result of an increase of COVID-19 cases in this region.

Moreover, the Europe market has been persistently growing over the forecast period. Due to the increased incidence of infectious diseases and hospital-acquired infections, the healthcare industry is now forced to use state-of-the-art hospital supplies.

Additionally, due to the increasing emphasis placed on green energy and carbon emission reduction by government bodies through policies and initiatives, Asia Pacific has been among COVID-19's hardest-hit geographical areas. A substantial number of COVID-19 cases have also been recorded from China and South Korea. The region's densely populated areas also contributed to the virus's quicker spread through towns.

Furthermore, the rest of the world's disposable hospital supplies market is divided into the Middle East, Africa, and Latin America. Asia Pacific has been among COVID-19's hardest-hit geographical areas. A substantial number of COVID-19 cases have also been recorded from China and South Korea. The region's densely populated areas also contributed to the virus's quicker spread through towns.

Key Findings of the Study

• The global disposable hospital supplies market is expected to reach USD 72.1 Billion by 2032, at a CAGR of 11.90% during the forecast period.


• The Asia-Pacific region accounted for the fastest-growing global market due to the due to the increasing emphasis placed on green energy and carbon emission reduction by government bodies through policies and initiatives


• Based on type, the sterilization consumables segment was attributed to holding the largest market in 2022, with an approximate market share of 55.45%.


• Thermo Fisher Scientific, GENERAL ELECTRIC, BD, Siemens, Boston Scientific Corporation, Stryker, Medtronic, 3M, Zimmer Biomet, Johnson and Johnson Private Limited, Cardinal Health, Koninklijke Philips N.V., Novartis AG, B. Braun Melsungen AG, OSI Systems, Inc., Welch Allyn, Fresenius Medical Care AG and Co. KGaA, Mindray DS USA, MicroPort Scientific Corporation, OandM Halyard, AVITA Medical, Cynosure Inc., and Merz Pharma